B37 is a San Francisco-based venture capital firm that focuses on early-stage technology startups in sectors such as Enterprise SaaS, Planetary Health, Logistics & Transportation, Data, Finance, and Engineered Biology. Their strategy involves leveraging a proprietary platform to connect startups with global corporations for product-market fit validation, accelerated go-to-market, and enterprise-scale growth.
Portfolio
4
Fund Size
$130M
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Tessell | Series B | $60M | Apr 2025 |
| Oobli | Series B | $18M | Feb 2025 |
| Ansa | Series A | $14M | Apr 2024 |
| Ansa | Series A | $19.6M | — |
Top Co-Investors
Bain Capital Ventures2 shared
Box Group2 shared
Lever VC1 shared
Khosla Ventures1 shared
Piva1 shared
Renegade Partners1 shared
Wischoff Ventures1 shared
WestBridge Capital1 shared
Lightspeed Venture Partners1 shared
Last updated: 3 March 2026